Global Therapeutic Ultrasound Devices Market Strategic Research Report

Scope of the Report

The global Therapeutic Ultrasound Devices market size is predicted to grow from US$ 5,303 million in 2025 to US$ 8,874 million in 2032; it is expected to grow at a CAGR of 7.7% from 2026 to 2032.

Therapeutic ultrasound devices refer to medical device systems that utilize the mechanical effects, thermal effects, and physicochemical effects of ultrasound to treat human diseases. According to the Medical Device Classification Catalog of the National Medical Products Administration, therapeutic ultrasound devices cover multiple categories, including high-intensity focused ultrasound systems for tumor ablation, surgical ultrasound devices for surgical procedures, ultrasound therapy devices for physical rehabilitation, and focused ultrasound skin treatment devices for aesthetic medicine applications. Their core working principle involves converting electrical energy into ultrasonic energy, which is emitted through transducers at specific frequencies and acoustic intensities to act on human tissues. This produces thermal effects that cause coagulative necrosis of diseased tissues, achieves tissue fragmentation and emulsification through mechanical vibration, or stimulates tissue repair and regeneration through low-intensity ultrasound. From an industrial value perspective, therapeutic ultrasound devices,凭借 their non-invasive or minimally invasive characteristics, precise targeting capabilities, and favorable safety profiles, have become important technological tools in oncology, surgery, rehabilitation therapy, and medical aesthetics, occupying an increasingly prominent strategic position in the global medical device market.

Market Development Opportunities and Key Drivers

China has 217 million people aged 65 and above, with deep aging driving rigid growth in demand for degenerative disease treatments. On the technological innovation front, high-intensity focused ultrasound has achieved breakthroughs. The first human clinical trial in November 2025 showed that the novel HIFU device MS-2 combined with nanomicellar epirubicin for advanced abdominal tumors achieved a disease control rate of 66.7% with no grade 3 or higher adverse events. On the policy front, in February 2026, the National Medical Products Administration approved the country's first intravascular ultrasound guidewire system for interventional treatment of chronic total occlusion of coronary arteries, filling a technological gap.

Market Challenges and Risks

Core technologies and components for high-end ultrasound equipment have long been dominated by foreign brands, with gaps still existing in the ultra-high-end segment. The escalation of US-China tariff disputes in 2025 saw China impose a 34% tariff on medical imaging equipment from the US, while the US doubled tariffs on Chinese semiconductors to 50%, driving up costs and forcing the acceleration of local supply chain development. In the medical aesthetics field, there have been issues of off-label use and exaggerated claims. Regulators have clarified that focused ultrasound is only approved for fat reduction, while its use for facial wrinkles and skin tightening is not approved, necessitating enhanced compliance.

Downstream Demand Trends

In the cardiovascular intervention field, the intravascular ultrasound treatment device approved in February 2026 is a domestic first. In medical aesthetics, Peninsula Medical released the country's first Class III focused ultrasound skin treatment device in December 2025, with nearly 6,000 hospitals already covering similar products, driving industry standardization. In oncology, novel modalities such as sonodynamic therapy are expanding, with HIFU combined with sonosensitizers showing potential to improve prognosis for patients with refractory tumors. The demand for ultrasound treatment equipment in primary medical institutions continues to grow with the implementation of the tiered diagnosis and treatment system, but a shortage of specialized talent constrains the effectiveness of technology deployment.

Regional Trends

North America leads cutting-edge innovation in HIFU, sonodynamic therapy, and other fields with its mature R&D systems, hosting the first human clinical trial of HIFU combined with sonosensitizers in November 2025. Europe maintains its technological advantages in ultrasound surgical equipment and core component development. The Asia-Pacific region shows the most active growth, with China becoming a global focal point driven by policy support and domestic substitution: domestic ultrasound equipment market share reached 65% in 2025, with Mindray's ultra-high-end ultrasound Resona A20 priced 100% higher than its predecessor and planned for FDA approval in 2025. Of the 281 innovative products approved by the National Medical Products Administration in 2024, 245 were domestic. United Imaging plans to launch its full ultrasound product line at the RSNA conference in December 2025, expanding into overseas markets. Hainan Free Trade Port's zero-tariff policy provides a buffer for imported high-end equipment while simultaneously driving technological iteration.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Therapeutic Ultrasound Devices market?

What factors are driving Therapeutic Ultrasound Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Therapeutic Ultrasound Devices market opportunities vary by end market size?

How does Therapeutic Ultrasound Devices break out by Type, by Application?

This report presents a comprehensive overview of the global Therapeutic Ultrasound Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Non-Invasive Therapeutic Ultrasound
• Minimally Invasive Therapeutic Ultrasound
• Intravascular Therapeutic Ultrasound

Segment by Technology

• Thermal Ablation
• Sonodynamic Therapy
• Mechanical Vibration
• Cavitation

Segment by Energy Strength

• High Intensity Focused
• Medium Intensity Broad-Beam
• Low Intensity Pulsed

Segment by Treatment Mode

• Continuous Mode
• Pulsed Mode
• Triggered Mode

Segment by Application

• Oncology
• Urology
• Cardiovascular
• Medical Aesthetics
• Musculoskeletal Rehabilitation

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Therapeutic Ultrasound Devices market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Oncology, Urology, Cardiovascular evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact